cdc.gov/coronavirus

ACIP COVID-19 Vaccines Work Group

Dr. Matthew F. Daley, Work Group Chair

September 22, 2021
Daily trends in number of COVID-19 cases in the United 

States 

CDC. https://covid.cdc.gov/covid-data-tracker/#trends_dailycases. Accessed September 19, 2021

January 23, 2020 – September 17, 2021

41,915,285 total cases

2
Daily trends in the number of COVID-19 deaths in the 

United States

CDC. https://covid.cdc.gov/covid-data-tracker/#trends_dailydeaths. Accessed September 19, 2021

January 23, 2020 – September 17, 2021

New Deaths: 2,087

7-day Moving Avg. Deaths: 1,520

3
 Considerations for booster doses of COVID-19 vaccines

– Real-world vaccine effectiveness studies (U.S. and abroad)

– RCT safety and immunogenicity of booster doses

– Modeling of the impact of booster doses on COVID-19 in nursing homes

– NIH booster data

– Outbreaks among vaccinated people in congregate settings

– GRADE of booster evidence

– COVID-19 vaccine booster doses: Benefit/risk analysis

– EtR: implementation, values, acceptability, resource use, equity

COVID-19 Work Group activities – August/September 2021

4
 Safety & immunogenicity of a 3rd dose BNT162b2 COVID-19 vaccine Dr. Gruber (Pfizer)

 Immunity and SARS-CoV-2 Dr. Thornburg (CDC)

Break

 Vaccine effectiveness studies in the U.S. Dr Link-Gelles (CDC)

 Modeling impact of booster doses in nursing home residents Dr. Slayton (CDC)

Break

 Early safety monitoring: 3rd doses Dr. Hause (CDC)

 VaST summary Dr. Talbot (VaST Co-chair)

 COVID-19 Work Group summary Dr. Oliver (CDC)

Break

 Pregnancy: Safety monitoring in v-safe Dr. Olson (CDC)

 Pregnancy: Safety monitoring in VSD Dr. Kharbanda (CDC)

 Updates on COVID-19 and pregnancy Dr. Meaney Delman (CDC)

Today's Agenda: Day #1-- Wednesday, September 20, 2021
 Public Comment

Break

 COVID-19 vaccine booster doses: Benefit/risk Dr. Wallace (CDC)

 Evidence to Recommendation Framework Dr. Oliver (CDC)

 Clinical considerations Dr. Dooling (CDC)

-VOTE- BNT162b2 COVID-19 vaccine booster dose

Day #2
ACIP members

 Matthew Daley (chair)

 Beth Bell 

 Grace Lee

 Keipp Talbot

 Oliver Brooks

Ex-officio/government members

 FDA: Doran Fink, Rachel Zhang

 NIH: Chris Roberts

 IHS: Thomas Weiser, Uzo Chukwuma

 DOD: Bryan Schumacher

 CMS: Jeff Kelman

 BARDA: Christine Oshansky

 HHS: David Kim

CDC Leads

 Sara Oliver

 Kathleen Dooling

Work group members

7

Liaisons

 AAFP: Jonathan Temte

 AAP: Sean O’Leary

 ACOG: Denise Jamieson (primary), 

Laura Riley (alternate)

 ACP: Jason Goldman

 AGS: Ken Schmader

 AIM: Rob Shechter (primary), 

Jane Zucker (alternate)

 AMA: Sandra Fryhofer

 ANA: Kendra McMillan (primary), 

Ruth Francis (alternate)

 APhA: Michael Hogue

 ASTHO: Marcus Plescia

 CSTE: Susan Lett (primary), 

Christine Hahn (alternate)

 IDSA: Jeff Duchin (primary), 

Carol Baker (alternate)

Liaisons, cont’d

 NACCHO: Matt Zahn (primary), 

Jeff Duchin (alternate)

 NACI: Matthew Tunis 

 NFID: Bill Schaffner (primary), 

Marla Dalton (alternate)

 NMA: Patricia Whitley-Williams

 SHEA: Marci Drees

Consultants

 Ed Belongia 

 Kathy Kinlaw 

 Dayna Matthew 

 Kathleen Neuzil 

 Stanley Perlman 

 Peter Szilagyi

 Jose Romero
 Mary Chamberland

 Neela Goswami

 Amanda Cohn

 Kathleen Dooling

 Julia Gargano

 Jack Gersten

 Monica Godfrey

 Stephen Hadler

 Sara Oliver

 Danielle Moulia

 Heidi Moline

 Megan Wallace

 Jennifer Collins

 Jefferson Jones

CDC participants

8

 Edwin Shanley

 Rita Helfand

 Cynthia Jorgensen

 Megan Lindley

 Nicole Lindsey

 Ruth Link-Gelles

 Jessica MacNeil

 Lauri Markowitz

 Jean Cox-Ganser

 Meredith McMorrow

 Amy Blain

 Andrew Kroger

 Melinda Wharton

 Kate Woodworth

 Yon Yu

 Kristin Nordland

 Kevin Chatham-Stevens

 Erin Tromble

 Dana Meaney-Delman

 Thomas Clark

 Sam Graitcer

 Lisa Grohskopf

 Anthony Fiore

 Rebecca Morgan

 Titilope Oduyebo

 Hannah Rosenblum

 Heather Scobie

 Edwin Shanley

 Tom Shimabukuro

 Natalie Thornburg

 Ian Plumb

 Thomas Clark

 Doug Campos-Outcalt

 Jillian Doss-Walker
For more information, contact CDC

1-800-CDC-INFO (232-4636)

TTY: 1-888-232-6348 www.cdc.gov

The findings and conclusions in this report are those of the authors and do not necessarily represent the 

official position of the Centers for Disease Control and Prevention.

Thank you!